Publications of C. W. Turck

Gassen, N. C.; Hartmann, J.; Zannas, A. S.; Kretzschmar, A.; Zschocke, J.; Maccarrone, G.; Hafner, K.; Zellner, A.; Kollmannsberger, L. K.; Wag, K. V. et al.; Mehta, D.; Kloiber, S.; Turck, C. W.; Lucae, S.; Chrousos, G. P.; Holsboer, F.; Binder, E. B.; Ising, M.; Schmidt, M. V.; Rein, T.: FKBP51 inhibits GSK3 beta and augments the effects of distinct psychotropic medications. MOLECULAR PSYCHIATRY 21 (2), pp. 277 - 289 (2016)

Kao, C.-Y.; He, Z.; Henes, K.; Asara, J. M.; Webhofer, C.; Filiou, M. D.; Khaitovich, P.; Wotjak, C. T.; Turck, C. W.: Fluoxetine Treatment Rescues Energy Metabolism Pathway Alterations in a Posttraumatic Stress Disorder Mouse Model. Molecular neuropsychiatry 2 (1), pp. 46 - 59 (2016)

Su, S.-Y.; Hogrefe-Phi, C. E.; Asara, J. M.; Turck, C. W.; Golub, M. S.: Peripheral fibroblast metabolic pathway alterations in juvenile rhesus monkeys undergoing long-term fluoxetine administration. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology 26 (7), pp. 1110 - 8 (2016)

Turck, C. W.; Webhofer, C.; Nussbaumer, M.; Teplytska, L.; Chen, A.; Maccarrone, G.; Filiou, M. D.: Stable isotope metabolic labeling suggests differential turnover of the DPYSL protein family. Proteomics. Clinical applications 10 (12), pp. 1269 - 1272 (2016)

Turck, C. W.; Webhofer, C.; Nussbaumer, M.; Teplytska, L.; Chen, A.; Maccarrone, G.; Filiou, M. D.: Stable isotope metabolic labeling suggests differential turnover of the DPYSL protein family. SI 10 (12), pp. 1269 - 1272 (2016)

Martins-de-Souza, D.; Cassoli, J. S.; Nascimento, J. M.; Hensley, K.; Guest, P. C.; Pinzon-Velasco, A. M.; Turck, C. W.: The protein interactome of collapsin response mediator protein-2 (CRMP2/DPYSL2) reveals novel partner proteins in brain tissue. PROTEOMICS CLINICAL APPLICATIONS 9 (9-10 SI), pp. 817 - 831 (2015)

Fernandes, B. S.; Steiner, J.; Berk, M.; Molendijk, M. L.; Gonzalez-Pinto, A.; Turck, C. W.; Nardin, P.; Goncalves, C.-A.: Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications. MOLECULAR PSYCHIATRY 20 (9), pp. 1108 - 1119 (2015)

Guest, P. C.; Iwata, K.; Kato, T. A.; Steiner, J.; Schmitt, A.; Turck, C. W.; Martins-de-Souza, D.: MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia. FRONTIERS IN CELLULAR NEUROSCIENCE 9, 180 (2015)

Wagner, K. V.; Hartmann, J.; Labermaier, C.; Häusl, A. S.; Zhao, G.; Harbich, D.; Schmid, B.; Wang, Xiao, X.-D.; Santarelli, S.; Kohl, C. et al.; Gassen, N. C.; Matosin, N.; Schieven, M.; Webhofer, C.; Turck, C. W.; Lindemann, L.; Jaschke, G.; Wettstein, J. G.; Rein, T.; Müller, M. B.; Schmidt, M. V.: Homer1/mGluR5 Activity Moderates Vulnerability to Chronic Social Stress. NEUROPSYCHOPHARMACOLOGY 40 (5), pp. 1222 - 1233 (2015)

Vogl, A. M.; Brockmann, M. M.; Giusti, S. A.; Maccarrone, G.; Vercelli, C. A.; Bauder, C. A.; Richter, J. S.; Roselli, F.; Hafner, A.-S.; Dedic, N. et al.; Wotjak, C. T.; Vogt-Weisenhorn, D. M.; Choquet, D.; Turck, C. W.; Stein, V.; Deussing, J. M.; Refojo, D.: Neddylation inhibition impairs spine development, destabilizes synapses and deteriorates cognition. NATURE NEUROSCIENCE 18 (2), pp. 239 - 251 (2015)

Cheema, A. K.; Asara, J. M.; Wang, Y.; Neubert, T. A.; Tolstikov, V.; Turck, C. W.: The ABRF Metabolomics Research Group 2013 Study: Investigation of Spiked Compound Differences in a Human Plasma Matrix. Journal of biomolecular techniques: JBT 26 (3), pp. 83 - 9 (2015)

Filiou, M. D.; Soukupova, M.; Rewerts, C.; Webhofer, C.; Turck, C. W.; Maccarrone, G.: Variability assessment of N-15 metabolic labeling-based proteomics workflow in mouse plasma and brain. MOLECULAR BIOSYSTEMS 11 (6), pp. 1536 - 1542 (2015)

Scarr, E.; Millan, M. J.; Bahn, S.; Bertolino, A.; Turck, C. W.; Kapur, S.; Moller, H.-J.; Dean, B.: Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank. The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 18 (10), pp. 1 - 9 (2015)

Steiner, J.; Martins-de-Souza, D.; Schiltz, K.; Sarnyai, Z.; Westphal, S.; Isermann, B.; Dobrowolny, H.; Turck, C. W.; Bogerts, B.; Bernstein, H.-G. et al.; Horvath, T. L.; Schild, L.; Keilhoff, G.: Clozapine promotes glycolysis and myelin lipid synthesis in cultured oligodendrocytes. FRONTIERS IN CELLULAR NEUROSCIENCE 8, 384 (2014)

Filiou, M. D.; Asara, J. M.; Nussbaumer, M.; Teplytska, L.; Landgraf, R.; Turck, C. W.: Behavioral extremes of trait anxiety in mice are characterized by distinct metabolic profiles. JOURNAL OF PSYCHIATRIC RESEARCH 58, pp. 115 - 122 (2014)

He, Y.; Hogrefe, C. E.; Grapov, D.; Palazoglu, M.; Fiehn, O.; Turck, C. W.; Golub, M. S.: Identifying individual differences of fluoxetine response in juvenile rhesus monkeys by metabolite profiling. TRANSLATIONAL PSYCHIATRY 4, e478 (2014)

Weckmann, K.; Labermaier, C.; Asara, J. M.; Müller, M. B.; Turck, C. W.: Time-dependent metabolomic profiling of Ketamine drug action reveals hippocampal pathway alterations and biomarker candidates. TRANSLATIONAL PSYCHIATRY 4, e481 (2014)

Wood, P. L.; Filiou, M. D.; Otte, D. M.; Zimmer, A.; Turck, C. W.: Lipidomics reveals dysfunctional glycosynapses in schizophrenia and the G72/G30 transgenic mouse. SCHIZOPHRENIA RESEARCH 159 (2-3), pp. 365 - 369 (2014)

Martins-de-Souza, D.; Maccarrone, G.; Ising, M.; Kloiber, S.; Lucae, S.; Holsboer, F.; Turck, C. W.: Blood Mononuclear Cell Proteome Suggests Integrin and Ras Signaling as Critical Pathways for Antidepressant Treatment Response. BIOLOGICAL PSYCHIATRY 76 (7), pp. E15 - E17 (2014)

Fernandes, B. S.; Berk, M.; Turck, C. W.; Steiner, J.; Goncalves, C.-A.: Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis. MOLECULAR PSYCHIATRY 19 (7), pp. 749 - 751 (2014)